Arboviruses: A Global Public Health Threat

Overview

Journal Vaccine

Specialty Allergy & Immunology

Date 2020 Apr 28

PMID 32336601

Citations 81

Authors

Marc Girard

Christopher B Nelson

Valentina Picot

Duane J Gubler

Affiliations

Soon will be listed here.

Abstract

A conference on «ARBOVIRUSES, A GLOBAL PUBLIC HEALTH THREAT» was organized on June 20-22, 2018 at the Merieux Foundation Conference Center in Veyrier du Lac, France, to review and raise awareness to the global public health threat of epidemic arboviruses, and to advance the discussion on the control and prevention of arboviral diseases. The presentations by scientists and public health officials from Asia, the Americas, Europe and Africa strengthened the notion that arboviral diseases of both humans and domestic animals are progressively becoming dominant public health problems in the world. The repeated occurrence of recent deadly epidemics strongly reinforces the call for action against these viral diseases, and the need for developing effective vaccines, drugs, vector control tools and strong prevention programs.

Citing Articles

Asian tiger mosquito in the oil-producing city of Soyo: the first report of Aedes (Stegomyia) albopictus (Skuse, 1894) in Angola.

Franco Martins J, Dina Troco A, Marques C, Chipepa V, Seixas G, Pinto J Parasit Vectors. 2025; 18(1):90.

PMID: 40045410 PMC: 11884181. DOI: 10.1186/s13071-025-06741-y.

Emerging Arboviral Diseases in Pakistan: Epidemiology and Public Health Implications.

Ammar M, Moaaz M, Yue C, Fang Y, Zhang Y, Shen S Viruses. 2025; 17(2).

PMID: 40006987 PMC: 11860545. DOI: 10.3390/v17020232.

DNA-Based Nanobiosensor for the Colorimetric Detection of Dengue Virus Serotype 2 Synthetic Target Oligonucleotide.

Flores M, Alocilja E, Amalin D, Aguila M, Purificacion M, Merca F Biosensors (Basel). 2025; 15(2).

PMID: 39996973 PMC: 11853087. DOI: 10.3390/bios15020071.

Arbovirus Epidemics as Global Health Imperative, Africa, 2023.

Bangoura S, Keita A, Diaby M, Sidibe S, Le-Marcis F, Camara S Emerg Infect Dis. 2025; 31(2):1-8.

PMID: 39983695 PMC: 11845133. DOI: 10.3201/eid3102.240754.

Dengue: epidemiology, diagnosis methods, treatment options, and prevention strategies.

Kothari D, Patel N, Kumar Bishoyi A Arch Virol. 2025; 170(3):48.

PMID: 39915348 DOI: 10.1007/s00705-025-06235-3.

References

Reiter P . Aedes albopictus and the world trade in used tires, 1988-1995: the shape of things to come?. J Am Mosq Control Assoc. 1998; 14(1):83-94. View

Biswal S, Reynales H, Saez-Llorens X, Lopez P, Borja-Tabora C, Kosalaraksa P . Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents. N Engl J Med. 2019; 381(21):2009-2019. DOI: 10.1056/NEJMoa1903869. View

Kosack C, Page A, Klatser P . A guide to aid the selection of diagnostic tests. Bull World Health Organ. 2017; 95(9):639-645. PMC: 5578377. DOI: 10.2471/BLT.16.187468. View

Gubler D . The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis. 2007; 45(8):1039-46. DOI: 10.1086/521911. View

Saadatian-Elahi M, Horstick O, Breiman R, Gessner B, Gubler D, Louis J . Beyond efficacy: The full public health impact of vaccines. Vaccine. 2016; 34(9):1139-47. PMC: 11345718. DOI: 10.1016/j.vaccine.2016.01.021. View

Marchette N, Garcia R, Rudnick A . Isolation of Zika virus from Aedes aegypti mosquitoes in Malaysia. Am J Trop Med Hyg. 1969; 18(3):411-5. DOI: 10.4269/ajtmh.1969.18.411. View

Gubler D . Dengue, Urbanization and Globalization: The Unholy Trinity of the 21(st) Century. Trop Med Health. 2012; 39(4 Suppl):3-11. PMC: 3317603. DOI: 10.2149/tmh.2011-S05. View

Gubler D . Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998; 11(3):480-96. PMC: 88892. DOI: 10.1128/CMR.11.3.480. View

Casey R, Harris J, Ahuka-Mundeke S, Dixon M, Kizito G, Nsele P . Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Final Report. N Engl J Med. 2018; 381(5):444-454. PMC: 7064153. DOI: 10.1056/NEJMoa1710430. View

10.

Wilder-Smith A, Leong W . Importation of yellow fever into China: assessing travel patterns. J Travel Med. 2017; 24(4). DOI: 10.1093/jtm/tax008. View

11.

Sridhar S, Luedtke A, Langevin E, Zhu M, Bonaparte M, Machabert T . Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy. N Engl J Med. 2018; 379(4):327-340. DOI: 10.1056/NEJMoa1800820. View

12.

Samuel M, Maoz D, Manrique P, Ward T, Runge-Ranzinger S, Toledo J . Community effectiveness of indoor spraying as a dengue vector control method: A systematic review. PLoS Negl Trop Dis. 2017; 11(8):e0005837. PMC: 5578493. DOI: 10.1371/journal.pntd.0005837. View

13.

Guy B, Jackson N . Dengue vaccine: hypotheses to understand CYD-TDV-induced protection. Nat Rev Microbiol. 2015; 14(1):45-54. DOI: 10.1038/nrmicro.2015.2. View

14.

Brent S, Watts A, Cetron M, German M, Kraemer M, Bogoch I . International travel between global urban centres vulnerable to yellow fever transmission. Bull World Health Organ. 2018; 96(5):343-354B. PMC: 5985425. DOI: 10.2471/BLT.17.205658. View

15.

Anders K, Indriani C, Ahmad R, Tantowijoyo W, Arguni E, Andari B . The AWED trial (Applying Wolbachia to Eliminate Dengue) to assess the efficacy of Wolbachia-infected mosquito deployments to reduce dengue incidence in Yogyakarta, Indonesia: study protocol for a cluster randomised controlled trial. Trials. 2018; 19(1):302. PMC: 5984439. DOI: 10.1186/s13063-018-2670-z. View

16.

Kraemer M, Sinka M, Duda K, Mylne A, Shearer F, Barker C . The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus. Elife. 2015; 4:e08347. PMC: 4493616. DOI: 10.7554/eLife.08347. View

17.

Lambrechts L, Ferguson N, Harris E, Holmes E, McGraw E, ONeill S . Assessing the epidemiological effect of wolbachia for dengue control. Lancet Infect Dis. 2015; 15(7):862-6. PMC: 4824166. DOI: 10.1016/S1473-3099(15)00091-2. View

18.

Bhatt S, Gething P, Brady O, Messina J, Farlow A, Moyes C . The global distribution and burden of dengue. Nature. 2013; 496(7446):504-7. PMC: 3651993. DOI: 10.1038/nature12060. View

19.

Flasche S, Jit M, Rodriguez-Barraquer I, Coudeville L, Recker M, Koelle K . The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study. PLoS Med. 2016; 13(11):e1002181. PMC: 5127514. DOI: 10.1371/journal.pmed.1002181. View

20.

Gessner B, Kaslow D, Louis J, Neuzil K, OBrien K, Picot V . Estimating the full public health value of vaccination. Vaccine. 2017; 35(46):6255-6263. PMC: 11369760. DOI: 10.1016/j.vaccine.2017.09.048. View